Skip to content

The Clinical Utility of Cholangioscopy and Pancreatoscopy in the Diagnosis and Management of Pancreaticobiliary Disorders

The Clinical Utility of Cholangioscopy and Pancreatoscopy in the Diagnosis and Management of Pancreaticobiliary Disorders

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00861198
Enrollment
88
Registered
2009-03-13
Start date
2006-11-30
Completion date
2015-05-31
Last updated
2015-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorders of the Pancreas and Biliary Tree

Brief summary

At the time of endoscopic retrograde cholangiopancreatography (ERCP) examination of the pancreaticobiliary system is done indirectly by radiologic means. Contrast is injected into the bile and/or pancreatic duct and outline of the duct is then viewed by fluoroscopic imaging. Frequently this is followed by diagnostic maneuvers (tissue acquisition) or therapeutic interventions (stone removal, stent insertion). Direct visualization of the bile and pancreatic ducts (cholangioscopy/pancreatoscopy) was developed 15 years ago and was shown to be superior to the indirect radiological view. The procedure did not become widely used secondary to high procedure related costs and equipment prone to failure. Recently a much improved (more affordable and more durable) cholangioscope was developed and approved by the FDA. The goal of this study is to prospectively record our experience with cholangioscopy and pancreatoscopy performed as medically indicated as part of standard medical care.

Interventions

OTHERERCP as per medical indication

ERCP as per medical indication

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subject is 18 years or older. * Scheduled to undergo ERCP with cholangioscopy and/or pancreatoscopy at the University of Florida, Gainesville, FL as medically indicated. * Subject must be able to give informed consent

Exclusion criteria

* Any contraindication to ERCP. * The subject is unable to give informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Successful Procedure CompletionbaselineDefined based on the indication for SpyGlass. For cases involving biliary or pancreatic stones the procedure was considered successful when complete stone clearance was accomplished. For cases involving established or suspected nonstone-related lesions of the pancreatobiliary system, success was defined when all of the following criteria were met: successful advancement of the SpyScope to the desired target, adequate visualization of the area of interest and successful applications of all diagnostic and/or therapeutic maneuvers that were deemed necessary based on the endoscopic findings.

Countries

United States

Participant flow

Pre-assignment details

There were 88 participants who were enrolled into the study; however, 13 were excluded because they did not qualify for the SpyGlass examination.

Participants by arm

ArmCount
ERCP With Cholangioscopy and/or Pancretoscopy
Patients underwent ERCP and cholangiography or pancreatography with the Spyglass system.
75
Total75

Withdrawals & dropouts

PeriodReasonFG000
Overall StudySpyGlass Failed5

Baseline characteristics

CharacteristicERCP With Cholangioscopy and/or Pancretoscopy
Age, Continuous66 years
Region of Enrollment
United States
75 participants
Sex: Female, Male
Female
37 Participants
Sex: Female, Male
Male
38 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 75
serious
Total, serious adverse events
0 / 75

Outcome results

Primary

Successful Procedure Completion

Defined based on the indication for SpyGlass. For cases involving biliary or pancreatic stones the procedure was considered successful when complete stone clearance was accomplished. For cases involving established or suspected nonstone-related lesions of the pancreatobiliary system, success was defined when all of the following criteria were met: successful advancement of the SpyScope to the desired target, adequate visualization of the area of interest and successful applications of all diagnostic and/or therapeutic maneuvers that were deemed necessary based on the endoscopic findings.

Time frame: baseline

ArmMeasureGroupValue (NUMBER)
ERCP With Cholangioscopy and/or PancretoscopySuccessful Procedure CompletionSuccessful completion70 participants
ERCP With Cholangioscopy and/or PancretoscopySuccessful Procedure CompletionUnsuccessful/Failed5 participants

Source: ClinicalTrials.gov · Data processed: Mar 29, 2026